Know When to Change a Patient's Home Osteoporosis Meds

July 2017

The new Rx med, abaloparatide (Tymlos, TIM-lohs), will raise questions about evaluating osteoporosis meds in hospitalized patients.

Osteoporosis meds generally aren't considered necessary during hospitalization. In fact, your hospital may have a standing order to automatically discontinue these meds on admission.

But watch for times when you may want to alter a home regimen.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
300+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Learn More

Already a subscriber? Log in

Not sold to individuals

Anticoagulants Double-Check Dosing of Direct Oral Anticoagulants (DOACs) in Certain Patients
Antimicrobial Stewardship Know How to Use Procalcitonin Levels to Decrease Antibiotic Use
Nausea & Vomiting Consider Combining Antiemetics in Patients With Multiple PONV Risk Factors
Obstetrics Advise Adding Tranexamic Acid to Oxytocin to Treat Postpartum Hemorrhage
Inhalers Be Prepared to Handle Switches With New Fluticasone/Salmeterol Inhalers
Diabetes Be Aware Canagliflozin Might Increase Amputation Risk in Diabetes Patients
Corticosteroids Re-Evaluate When to Consider Using Short-Course Steroids
Osteoporosis Know When to Change a Patient's Home Osteoporosis Meds
Transdermal Patches Help Avoid Common Errors With Transdermal Patches
Parkinson's Disease Help Patients Safely Continue the New Parkinson's Med Safinamide in the Hospital
Musculoskeletal Be Aware That Meds Aren't Very Effective for Leg Cramps

Know When to Change a Patient's Home Osteoporosis Meds

Get unlimited access through an Enterprise license

Table of Contents